India Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Service Type, By Sponsor, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Phase
                        1.2.2. Study Design
                        1.2.3. Indication
                        1.2.4. Service Type
                        1.2.5. Sponsor
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. India Clinical Trials Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. India Clinical Trials Market: Phase Business Analysis
                    4.1. Phase Market Share, 2024 & 2030
                    4.2. Phase Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Phase, 2018 to 2030 (USD Million)
                    4.4. Phase I
                        4.4.1. Phase I Market, 2018 - 2030 (USD Million)
                    4.5. Phase II
                        4.5.1. Phase II Market, 2018 - 2030 (USD Million)
                    4.6. Phase III
                        4.6.1. Phase III Market, 2018 - 2030 (USD Million)
                    4.7. Phase IV
                        4.7.1. Phase IV Market, 2018 - 2030 (USD Million)
Chapter 5. India Clinical Trials Market: Study Design Business Analysis
                    5.1. Study Design Market Share, 2024 & 2030
                    5.2. Study Design Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Study Design, 2018 to 2030 (USD Million)
                    5.4. Interventional Trials
                        5.4.1. Interventional Trials Market, 2018 - 2030 (USD Million)
                    5.5. Observational Trials
                        5.5.1. Observational Trials Market, 2018 - 2030 (USD Million)
                    5.6. Expanded Access Trials
                        5.6.1. Expanded Access Trials Market, 2018 - 2030 (USD Million)
Chapter 6. India Clinical Trials Market: Indication Business Analysis
                    6.1. Indication Market Share, 2024 & 2030
                    6.2. Indication Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
                    6.4. Autoimmune/Inflammation
                        6.4.1. Autoimmune/Inflammation Market, 2018 - 2030 (USD Million)
                        6.4.2. Rheumatoid Arthritis
                            6.4.2.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
                        6.4.3. Multiple Sclerosis
                            6.4.3.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
                        6.4.4. Osteoarthritis
                            6.4.4.1. Osteoarthritis Market, 2018 - 2030 (USD Million)
                        6.4.5. Irritable Bowel Syndrome (IBS)
                            6.4.5.1. Irritable Bowel Syndrome (IBS) Market, 2018 - 2030 (USD Million)
                        6.4.6. Others
                            6.4.6.1. Others Market, 2018 - 2030 (USD Million)
                    6.5. Pain Management
                        6.5.1. Pain Management Market, 2018 - 2030 (USD Million)
                        6.5.2. Chronic Pain
                            6.5.2.1. Chronic Pain Market, 2018 - 2030 (USD Million)
                        6.5.3. Acute Pain
                            6.5.3.1. Acute Pain Market, 2018 - 2030 (USD Million)
                    6.6. Oncology
                        6.6.1. Oncology Market, 2018 - 2030 (USD Million)
                        6.6.2. Blood Cancer
                            6.6.2.1. Blood Cancer Market, 2018 - 2030 (USD Million)
                        6.6.3. Solid Tumors
                            6.6.3.1. Solid Tumors Market, 2018 - 2030 (USD Million)
                        6.6.4. Others
                            6.6.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.7. CNS Conditions
                        6.7.1. CNS Conditions Market, 2018 - 2030 (USD Million)
                        6.7.2. Epilepsy
                            6.7.2.1. Epilepsy Market, 2018 - 2030 (USD Million)
                        6.7.3. Parkinson's Disease (PD)
                            6.7.3.1. Parkinson's Disease (PD) Market, 2018 - 2030 (USD Million)
                        6.7.4. Huntington's Disease
                            6.7.4.1. Huntington's Disease Market, 2018 - 2030 (USD Million)
                        6.7.5. Stroke
                            6.7.5.1. Stroke Market, 2018 - 2030 (USD Million)
                        6.7.6. Traumatic Brain Injury (TBI)
                            6.7.6.1. Traumatic Brain Injury (TBI) Market, 2018 - 2030 (USD Million)
                        6.7.7. Amyotrophic Lateral Sclerosis (ALS)
                            6.7.7.1. Amyotrophic Lateral Sclerosis (ALS) Market, 2018 - 2030 (USD Million)
                        6.7.8. Muscle Regeneration
                            6.7.8.1. Muscle Regeneration Market, 2018 - 2030 (USD Million)
                        6.7.9. Others
                            6.7.9.1. Others Market, 2018 - 2030 (USD Million)
                    6.8. Diabetes
                        6.8.1. Diabetes Market, 2018 - 2030 (USD Million)
                    6.9. Obesity
                        6.9.1. Obesity Market, 2018 - 2030 (USD Million)
                    6.10. Cardiovascular
                        6.10.1. Cardiovascular Market, 2018 - 2030 (USD Million)
                    6.11. Others
                        6.11.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. India Clinical Trials Market: Service Type Business Analysis
                    7.1. Service Type Market Share, 2024 & 2030
                    7.2. Service Type Segment Dashboard
                    7.3. Market Size & Forecasts and Trend Analysis, by Service Type, 2018 to 2030 (USD Million)
                    7.4. Protocol Designing
                        7.4.1. Protocol Designing Market, 2018 - 2030 (USD Million)
                    7.5. Site Identification
                        7.5.1. Site Identification Market, 2018 - 2030 (USD Million)
                    7.6. Patient Recruitment
                        7.6.1. Patient Recruitment Market, 2018 - 2030 (USD Million)
                    7.7. Laboratory Services
                        7.7.1. Laboratory Services Market, 2018 - 2030 (USD Million)
                    7.8. Bioanalytical Testing Services
                        7.8.1. Bioanalytical Testing Services Market, 2018 - 2030 (USD Million)
                    7.9. Clinical Trial Data Management Services
                        7.9.1. Clinical Trial Data Management Services Market, 2018 - 2030 (USD Million)
                    7.10. Others
                        7.10.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. India Clinical Trials Market: Sponsor Business Analysis
                    8.1. Sponsor Market Share, 2024 & 2030
                    8.2. Sponsor Segment Dashboard
                    8.3. Market Size & Forecasts and Trend Analysis, by Sponsor, 2018 to 2030 (USD Million)
                    8.4. Pharmaceutical & Biopharmaceutical Companies
                        8.4.1. Pharmaceutical & Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
                    8.5. Medical Device Companies
                        8.5.1. Medical Device Companies Market, 2018 - 2030 (USD Million)
                    8.6. Others
                        8.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Participant Overview
                    9.2. Company Market Position Analysis
                    9.3. Company Categorization
                    9.4. Strategy Mapping
                    9.5. Company Profiles/Listing
                        9.5.1. IQVIA
                            9.5.1.1. Overview
                            9.5.1.2. Financial Performance
                            9.5.1.3. Phase Benchmarking
                            9.5.1.4. Strategic Initiatives
                        9.5.2. Parexel International (MA) Corporation
                            9.5.2.1. Overview
                            9.5.2.2. Financial Performance
                            9.5.2.3. Phase Benchmarking
                            9.5.2.4. Strategic Initiatives
                        9.5.3. Thermo Fisher Scientific Inc
                            9.5.3.1. Overview
                            9.5.3.2. Financial Performance
                            9.5.3.3. Phase Benchmarking
                            9.5.3.4. Strategic Initiatives
                        9.5.4. Charles River Laboratories
                            9.5.4.1. Overview
                            9.5.4.2. Financial Performance
                            9.5.4.3. Phase Benchmarking
                            9.5.4.4. Strategic Initiatives
                        9.5.5. ICON PLC
                            9.5.5.1. Overview
                            9.5.5.2. Financial Performance
                            9.5.5.3. Phase Benchmarking
                            9.5.5.4. Strategic Initiatives
                        9.5.6. Aurigene Oncology
                            9.5.6.1. Overview
                            9.5.6.2. Financial Performance
                            9.5.6.3. Phase Benchmarking
                            9.5.6.4. Strategic Initiatives
                        9.5.7. Aragen Life Sciences Ltd
                            9.5.7.1. Overview
                            9.5.7.2. Financial Performance
                            9.5.7.3. Phase Benchmarking
                            9.5.7.4. Strategic Initiatives
                        9.5.8. Syneos Health
                            9.5.8.1. Overview
                            9.5.8.2. Financial Performance
                            9.5.8.3. Phase Benchmarking
                            9.5.8.4. Strategic Initiatives
                        9.5.9. SGS Société Générale de Surveillance SA
                            9.5.9.1. Overview
                            9.5.9.2. Financial Performance
                            9.5.9.3. Phase Benchmarking
                            9.5.9.4. Strategic Initiatives
                        9.5.10. Syngene International Limited
                            9.5.10.1. Overview
                            9.5.10.2. Financial Performance
                            9.5.10.3. Phase Benchmarking
                            9.5.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. India clinical trials market, by phase, 2018 - 2030 (USD Million)
Table 4. India clinical trials market, by study design, 2018 - 2030 (USD Million)
Table 5. India clinical trials market, by indication, 2018 - 2030 (USD Million)
Table 6. India clinical trials market, by service type, 2018 - 2030 (USD Million)
Table 7. India clinical trials market, by sponsor, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 India clinical trials market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Phase outlook (USD Billion)
Fig. 10 Transportation mode outlook (USD Billion)
Fig. 11 Competitive landscape
Fig. 12 India clinical trials market dynamics
Fig. 13 India clinical trials market: Porter’s five forces analysis
Fig. 14 India clinical trials market: PESTLE analysis
Fig. 15 India clinical trials market: Phase segment dashboard
Fig. 16 India clinical trials market: Phase market share analysis, 2024 & 2030
Fig. 17 Phase I market, 2018 - 2030 (USD Million)
Fig. 18 Phase II market, 2018 - 2030 (USD Million)
Fig. 19 Phase III market, 2018 - 2030 (USD Million)
Fig. 20 Phase IV market, 2018 - 2030 (USD Million)
Fig. 21 India clinical trials market: Study Design segment dashboard
Fig. 22 India clinical trials market: Study Design market share analysis, 2024 & 2030
Fig. 23 Interventional trials market, 2018 - 2030 (USD Million)
Fig. 24 Observational trials market, 2018 - 2030 (USD Million)
Fig. 25 Expanded access trials market, 2018 - 2030 (USD Million)
Fig. 26 India clinical trials market: Indication segment dashboard
Fig. 27 India clinical trials market: Indication market share analysis, 2024 & 2030
Fig. 28 Autoimmune/inflammation market, 2018 - 2030 (USD Million)
Fig. 29 Rheumatoid arthritis market, 2018 - 2030 (USD Million)
Fig. 30 Multiple sclerosis market, 2018 - 2030 (USD Million)
Fig. 31 Osteoarthritis market, 2018 - 2030 (USD Million)
Fig. 32 Irritable bowel syndrome (IBS) market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Pain management market, 2018 - 2030 (USD Million)
Fig. 35 Chronic pain market, 2018 - 2030 (USD Million)
Fig. 36 Acute pain market, 2018 - 2030 (USD Million)
Fig. 37 Oncology market, 2018 - 2030 (USD Million)
Fig. 38 Blood cancer market, 2018 - 2030 (USD Million)
Fig. 39 Solid tumors market, 2018 - 2030 (USD Million)
Fig. 40 Other market, 2018 - 2030 (USD Million)
Fig. 41 CNS conditions market, 2018 - 2030 (USD Million)
Fig. 42 Epilepsy market, 2018 - 2030 (USD Million)
Fig. 43 Parkinson's disease (PD) market, 2018 - 2030 (USD Million)
Fig. 44 Huntington's disease market, 2018 - 2030 (USD Million)
Fig. 45 Stroke market, 2018 - 2030 (USD Million)
Fig. 46 Traumatic brain injury (TBI) market, 2018 - 2030 (USD Million)
Fig. 47 Amyotrophic lateral sclerosis (ALS) market, 2018 - 2030 (USD Million)
Fig. 48 Muscle regeneration market, 2018 - 2030 (USD Million)
Fig. 49 Others market, 2018 - 2030 (USD Million)
Fig. 50 Diabetes market, 2018 - 2030 (USD Million)
Fig. 51 Obesity market, 2018 - 2030 (USD Million)
Fig. 52 Cardiovascular market, 2018 - 2030 (USD Million)
Fig. 53 Others market, 2018 - 2030 (USD Million)
Fig. 54 India clinical trials market: Service Type segment dashboard
Fig. 55 India clinical trials market: Service Type market share analysis, 2024 & 2030
Fig. 56 Protocol designing market, 2018 - 2030 (USD Million)
Fig. 57 Site identification market, 2018 - 2030 (USD Million)
Fig. 58 Patient recruitment market, 2018 - 2030 (USD Million)
Fig. 59 Laboratory services market, 2018 - 2030 (USD Million)
Fig. 60 Bioanalytical testing services market, 2018 - 2030 (USD Million)
Fig. 61 Clinical trial data management services market, 2018 - 2030 (USD Million)
Fig. 62 Others market, 2018 - 2030 (USD Million)
Fig. 63 India clinical trials market: Sponsor segment dashboard
Fig. 64 India clinical trials market: Sponsor market share analysis, 2024 & 2030
Fig. 65 Pharmaceutical & biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 66 Medical device companies market, 2018 - 2030 (USD Million)
Fig. 67 Others market, 2018 - 2030 (USD Million)
Fig. 68 Company categorization
Fig. 69 Company market position analysis
Fig. 70 Strategic framework